输血诊断的全球市场:现状分析与预测(2021年～2027年)

全球输血诊断的市场规模在预测期间(2021年～2027年)中预计将以约7％的年复合成长率成长。

输血诊断市场增长的主要因素是老年人口的增加、全球外科手术的普及、伤害和创伤发生率的增加以及贫血、白血病、肾病患病率的迅速上升等增加。提高献血意识也被认为是市场增长的驱动力。

本报告提供全球输血诊断市场的相关调查，提供市场洞察，市场趋势，竞争模式，企业概要等全面性资讯。

目录

第1章 市场简介

• 市场定义
• 限制
• 相关利益者
• 报告所使用的货币

第2章 调查方法或假设

• 输血诊断市场调查流程
• 输血诊断市场调查手法
• 预测方法
• 受访者简介
• 输血诊断市场调查的主要目的

第3章 市场摘要

第4章 摘要整理

第5章 输血诊断市场上COVID-19影响

第6章 输血诊断市场收益(2019年～2027年)

第7章 市场洞察:各产品类型

• 试剂和套件
• 设备

第8章 市场洞察:各应用领域

• 血型分类
• 疾病筛检
  • 血清学的疾病筛检
  • 分子疾病筛检

第9章 市场洞察:各终端用户

• 医院
• 血库
• 诊断研究所
• 其他

第10章 市场洞察:各地区

• 北美
  • 美国
  • 加拿大
  • 其他的北美
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 其他的欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 其他的亚太地区
• 其他

第11章 输血诊断市场动态

• 推动市场要素
• 市场课题
• 影响分析

第12章 输血诊断市场机会

第13章 输血诊断市场趋势

第14章 相关法规

第15章 需求与供给面的分析

• 需求面分析
• 供给面分析

第16章 价值链分析

第17章 竞争模式

• 竞争情形
  • 波特的五力分析

第18章 公司概要

• Immucor Inc.
• Ortho Clinical Diagnostics
• Abbott Laboratories
• Bio-Rad Laboratories
• F. Hoffmann-La Roche AG
• Quotient Limited
• BAG Healthcare GmbH
• DiaSorin S.P.A.
• Danaher Corporation
• BIOKIT (Werfen)

第19章 免责声明

Blood transfusion diagnostics is expected to witness a CAGR of around ~7% during the forecast period (2021-2027). The key factors responsible for the growth of the market include the growing geriatric population, increasing prevalence of surgeries worldwide, high rate of injuries and trauma cases, and surging prevalence of anemia, leukemia, or kidney disease. Blood transfusion is usually done as a lifesaving operation to replace blood cells or blood products lost through severe bleeding, blood loss during surgery, or to increase the platelet count in the patient. According to the Community Blood Center, In America, 4.5 million people need blood transfusion each year. According to the World Health Organization (WHO), in low-income countries, up to 54 % of blood transfusions are given to children under 5 years of age, whereas in high-income countries, the most frequently transfused patient group is over 60 years of age, accounting for up to 76% of all transfusions. The rising geriatric population is also expected to drive the growth of the blood transfusion diagnostic market during the forecast period. Moreover, in the APAC region, there is a steady increase in the number of surgeries, accidents, blood donation centers, and blood donors, and a rise in awareness about blood donation will drive the market growth during the forecast period.

Immucor, Inc., Ortho Clinical Diagnostics, Abbott, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Quotient Limited, BAG Healthcare GmbH, DiaSorin S.P.A., Danaher, and BIO KIT (Werfen) are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

"Amongst Product, reagents and kits category accounted for the majority share in the market in 2020"

Based on product type, the blood transfusion diagnostics market is segmented into Reagents & Kits, and Instruments. In 2020, The reagents and kits category held the largest share and is anticipated to witness a considerable growth rate over the forecast period. The availability of technologically advanced donor screening analyzers will drive the growth of this segment. In addition, the rising availability of rapid diagnostic kits for safe blood transfusion is expected to boost the market growth. Furthermore, the rising prevalence of injuries and accidents across the world is also a major factor in the growth of this segment. According to CDC, every year an average of around 6 million car accident cases occurs in the U.S. Among them, approximately 3 million people are injured. Moreover, surgeries such as post-cardiopulmonary bypass, neurosurgery, posterior eye surgery, and chronic bleeding disorders also require platelet transfusions.

"Amongst Application, Disease Screening category is expected to witness highest CAGR during the forecast period"

Based on application type, the blood transfusion diagnostics market has been segmented into blood grouping, and disease screening. In 2020, the Disease Screening category held the largest share and is anticipated to witness a considerable growth rate over the forecast period. This can be due to a high number of transfusion-transmitted infection (TTI) cases, rising safety screening of donated blood, maintaining safe transfusion, rising technological advancements, and wide products offered by key players in the market. For instance, blood transfusion is a base in the treatment of anemic patients. Thus, the growing elderly population with iron deficiency is also supporting the market growth. According to World Health Organization (WHO), Anemia is a serious global public health problem that particularly affects young children and pregnant women. WHO estimates that 42% of children less than 5 years of age and 40% of pregnant women worldwide are anemic.

"Amongst End-User, blood banks category is expected to witness highest CAGR during the forecast period"

Based on end-users, the blood transfusion diagnostics market is segmented into hospitals, blood banks, diagnostic laboratories, and others. In 2020, the blood banks category dominated the blood transfusion diagnostics market and is expected to grow significantly in the upcoming years. The growth of this segment is due to rising surgical procedures, injuries, anemia, leukemia, and kidney failure treatment procedures. However, the blood bank segment is expected to grow in developing nations because of the geriatric population, and the increasing number of road accidents. Also, the increasing awareness of blood donation in developing countries is also one of the prominent factors due to which the blood bank segment is expected is grow in the forecast period.

"North America to witness significant growth during the forecast period"

Geographically, North America is expected to lead the blood transfusion diagnostics market throughout the analysis period. This can be attributed to the greater presence of industry players, high healthcare spending, and increase in research and development (R&D) activities in the region. Furthermore, an increase in the number of surgeries, a rising number of road accidents coupled with a surge in the number of cancer cases such as leukemia, lymphoma, and myeloma. These are some of the drivers of the North American blood transfusion diagnostics market. In addition, according to the Leukemia and Lymphoma Society (LLS), An estimated combined total of 186,400 people in the US are expected to be diagnosed with leukemia, lymphoma, or myeloma in 2021. and new cases of leukemia, lymphoma, and myeloma are expected to account for 9.8 percent of the estimated 1,898,160 new cancer cases that will be diagnosed in the US in 2021. moreover, increasing health awareness, high disposable income, favorable reimbursement policies, and well-established healthcare infrastructure are some of the key factors boosting the regional market.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

• The report presents a quick review of overall industry performance at one glance.

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional level analysis of the industry.

Customization Options:

The blood transfusion diagnostics Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stake Holders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Blood Transfusion Diagnostics Market
• 2.2. Research Methodology of the Blood Transfusion Diagnostics Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Blood Transfusion Diagnostics Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 BLOOD TRANSFUSION DIAGNOSTICS MARKET COVID-19 IMPACT

6 BLOOD TRANSFUSION DIAGNOSTICS MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

• 7.1. Reagents & Kits
• 7.2. Instruments

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Blood Grouping
• 8.2. Disease Screening
  • 8.2.1. Serological Disease Screening
  • 8.2.2. Molecular Disease Screening

9 MARKET INSIGHTS BY END-USER

• 9.1. Hospitals
• 9.2. Blood Banks
• 9.3. Diagnostic Laboratories
• 9.4. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Spain
  • 10.2.5. Italy
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. India
  • 10.3.3. Japan
  • 10.3.4. Australia
  • 10.3.5. Rest of Asia-Pacific
• 10.4. Rest of the World

11 BLOOD TRANSFUSION DIAGNOSTICS MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 BLOOD TRANSFUSION DIAGNOSTICS MARKET OPPORTUNITIES

13 BLOOD TRANSFUSION DIAGNOSTICS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY-SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

• 18.1. Immucor Inc.
• 18.2. Ortho Clinical Diagnostics
• 18.3. Abbott Laboratories
• 18.4. Bio-Rad Laboratories
• 18.5. F. Hoffmann-La Roche AG
• 18.6. Quotient Limited
• 18.7. BAG Healthcare GmbH
• 18.8. DiaSorin S.P.A.
• 18.9. Danaher Corporation
• 18.10. BIOKIT (Werfen)

19 DISCLAIMER